Sector pending / In Vitro and In Vivo Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/04X stock hub

FRA/04X has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/04Xis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

532M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/04XFRA/04X

—

Loading chart…

In the news

Latest news · FRA/04X

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-41.4

P25 n/aP50 n/aP75 n/a

ROIC-23.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/04X market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

168

Groups with data

Currency

USD

Showing 168 of 168 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	260
Employees Change	4%
Employees Change Percent	1.78
Enterprise value	EUR 366.9M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	In Vitro and In Vivo Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 532M
Price	EUR 4.97
Price currency	EUR
Rev Per Employee	215,207.15x
Sic	2835
Symbol	fra/04X
Website	https://www.personalis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-15.58%
EV Earnings	-4.43x
EV/FCF	-5x
EV/Sales	6.69x
FCF yield	-13.8%
P/B ratio	2.41x
P/S ratio	9.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-158.91%
EBITDA Margin	-143.68%
Gross margin	13.72%
Gross Profit	EUR 7.7M
Gross Profit Growth	-68.99%
Gross Profit Growth Q	-96.1%
Gross Profit Growth3 Y	-13.77%
Gross Profit Growth5 Y	-17.74%
Net Income	EUR -82.9M
Pretax Margin	-148.06%
Profit Margin	-148.11%
Profit Per Employee	EUR -318,739
ROA	-21.41
Roa5y	-18.47
ROCE	-35.8
ROE	-41.35
Roe5y	-42.99
ROIC	-23.47

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	24.81%
Cagr3y	34.28%
Cagr5y	-23.55%
Revenue Growth	-24.72x
Revenue Growth Q	-24.91x
Revenue Growth3 Y	-2.06x
Revenue Growth5 Y	-4.3x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.22
Assets	EUR 282.2M
Cash	EUR 202.3M
Current Assets	EUR 218.9M
Current Liabilities	EUR 33.1M
Debt	EUR 33.6M
Debt Equity	EUR 0.15
Debt FCF	EUR -0.46
Equity	EUR 221M
Interest Coverage	-457.7
Liabilities	EUR 61.3M
Long Term Assets	EUR 63.3M
Long Term Liabilities	EUR 28.1M
Net Cash	EUR 168.6M
Net Cash By Market Cap	EUR 31.7
Net Cash Growth	38.43%
Net Debt Equity	EUR -0.76
Tangible Book Value	EUR 221M
Tangible Book Value Per Share	EUR 2.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.61
Inventory Turnover	11.76
Net Working Capital	EUR -5.5M
Quick ratio	6.31
Working Capital	EUR 190.1M
Working Capital Turnover	EUR 0.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-36.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	24.79%
200-day SMA	6.32
3Y total return	142.15%
50-day SMA	5.85
50-day SMA vs 200-day SMA	50under200
5Y total return	-73.89%
All Time High	43.4
All Time High Change	-88.55%
All Time High Date	2021-01-20
All Time Low	0.83
All Time Low Change	496.16%
All Time Low Date	2023-11-08
ATR	0.27
Ch YTD	-24.37
High	4.97
High52	9.76
High52 Date	2026-01-23
High52ch	-49.09%
Low	4.97
Low52	3.66
Low52 Date	2025-08-06
Low52ch	35.69%
Ma50ch	-15.03%
Price vs 200-day SMA	-21.39%
RSI	45.61
RSI Monthly	49.02
RSI Weekly	42.55
Sharpe ratio	0.54x
Sortino ratio	0.89
Total Return	-36.49%
Tr YTD	-24.37
Tr1m	-10.05%
Tr1w	3.05%
Tr3m	-19.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -88.9M
Operating margin	-158.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	68,195,642%
Net Borrowing	-4,322,062.3
Shares Insiders	1.18%
Shares Institutions	56.2%
Shares Qo Q	12.91%
Shares Yo Y	36.49%
Short Ratio	7.2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -81.9M
Average Volume	68.4x
Bv Per Share	2.11
CAPEX	EUR -4.5M
Ch1m	-10.05
Ch1w	3.05
Ch1y	24.79
Ch3m	-19.6
Ch3y	142.2
Ch5y	-73.89
Ch6m	-18.81
Change	-2.76%
Change From Open	0
Close	5.11
Days Gap	-2.76
Depreciation Amortization	8,335,466.5
Earnings Date	2026-05-07
EBIT	EUR -88.9M
EBITDA	EUR -80.4M
EPS	EUR -0.89
F Score	1
FCF	EUR -73.4M
FCF EV Yield	-20.01x
Financing CF	111,084,651
Fiscal Year End	December
Founded	2,011
Income Tax	EUR 26,019
Investing CF	-39,928,757
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Ma150	6.93
Ma150ch	-28.28%
Ma20	5.11
Ma20ch	-2.68%
Net CF	2,248,909
Next Earnings Date	2026-08-07
Open	4.97
Ppne	53,756,551
Price Date	2026-05-08
Ptbv Ratio	2.41
Relative Volume	0.76x
Revenue	55,953,860x
SBC By Revenue	15.13x
Share Based Comp	8,467,450
Tax By Revenue	0.05x
Tr6m	-18.81%
Volume	0
Z Score	2.4

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/04X pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/04X stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/04X?

Insider, institutional, and short-interest positioning.

Institutional ownership

+56.2%

Share of float held by funds and institutions

Insider ownership

+1.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/04X momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.6

Neutral momentum band

Price vs 200-day MA

-21.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.54

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/04X

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/04X stock rating?

fra/04X is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/04X analysis?

The full report lives at /stocks/fra/04X/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/04X?

The latest report frames fra/04X around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/04X page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.